ArticleBioengineering (Basel, Switzerland)2026
Segmentation Methodologies for the Construction of Hyperspectral Cell Nuclei Databases in Histopathology.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hyperspectral imaging (HSI) extends conventional histopathology by combining spatial morphology with rich spectral information that reflects tissue biochemical composition, offering new opportunities for quantitative tissue analysis. However, reliable spectral analysis requires accurate instance-level segmentation of cell nuclei to enable the construction of meaningful nuclear spectral databases. In this work, a comprehensive methodology for generating hyperspectral databases of cell nuclei from histopathological samples is presented, including hyperspectral acquisition, preprocessing, nucleus segmentation, and spectral signature extraction. Three nucleus segmentation methods are evaluated: a spectral-only approach based on pixel-wise hyperspectral signatures in the visible-VNIR range; a spatial-only approach using synthetic RGB images derived from hyperspectral cubes; and a combined spatial-spectral approach that jointly exploits spatial and spectral information. The methods are assessed on a proprietary dataset of 30 hyperspectral cubes of tumor and healthy histopathological brain tissue annotated by expert pathologists. The spectral-only method achieves a Dice similarity coefficient (DSC) of 61.89% and produces severe over-segmentation, with cell count deviations exceeding substantially the ground truth in healthy tissue. The spatial-only method attains the highest pixel-wise accuracy (78.97% DSC) but underestimates nucleus counts by approximately 30% in tumor regions due to nucleus merging. The spatial-spectral method achieves a DSC of 73.13% and a mean cell count deviation of 4%, providing more reliable instance-level separation. These findings demonstrate that pixel-wise accuracy alone is insufficient for hyperspectral nuclear database generation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.